Monthly Archives: March 2020

#V3PODCAST Episode 7: Coronavirus – Productivity & Continued Preparedness in Medical Affairs

Coronavirus – Productivity & Continued Preparedness in Medical Affairs

#V3Podcast Episode 7 with Dr. Anne Arvizu and Guest Dr. Suzanne Soliman

In this episode, Anne provides excellent resources and links to use for knowledge base, as a means to keep up with true facts and help you and your loved ones say no to fear and false information. This podcast is meant to help healthcare professionals protect themselves and inform others. Almost every industry in the US and beyond at this point has made a massive shift and Anne shares valuable consulting advice regarding the re-direct toward a new normal in Medical Affairs, Medical Communications, Publications and Medical Information. Any company, especially those working on Coronavirus vaccines or antiviral solutions may contact RxER Communications at support@rxercommunications.com to schedule a free consultation and strategy call with Anne.

Focus:

The aim of today’s episode today, is providing guidance for the current changes in the Biotech industry.

The tone of this planned podcast has shifted dramatically in the last week since taping on March 12.  Every day, and even every hour brings with it significant changes as we track. It’s time to not be caught up in the news, but be educated with the facts and forge our new normal.

During the first half, Anne discusses how HCPs (Pharmacists, Physicians, Nurses) are affected and then opens up the second half of the show with a conversation with special guest expert, Dr. Suzanne Soliman, on continued prevention measures to help answer the most common questions we are all receiving right now from the lay public. The aim is to hopefully better equip, protect and prepare the health professional so they can better help and continue to prepare others. Although it is not mentioned in the show, our biggest risk factor right now in the US, is Millennials who continue to go out, travel and not take this seriously. It’s been said the virus rate will depend on them.

It’s a time to stay home and distance yourself from other people as much as possible.

Anne invited Suzanne Soliman, founder of the Pharmacist Mom’s Group, on the show to discuss preparedness; Suzanne earned her PharmD from the University of Illinois at Chicago College of Pharmacy (UIC-COP) in 2004. She completed a residency in primary care with an emphasis on education at Midwestern University Chicago College of Pharmacy and a teaching fellowship at UIC College of Medicine.

Dr. Suzanne Soliman is a board-certified medical affairs specialist (BCMAS). Suzy worked as a clinical pharmacist, a medical science liaison (MSL) and national field team educator prior to becoming an Assistant Dean of Academic Affairs at UIC-COP. She most recently was an Associate Dean at Touro College of Pharmacy New York and an independent pharmacy owner. Currently, she is the Chief Academic Officer for the Accreditation Council for Medical Affairs (ACMA).

More Key Points:

It’s only been two weeks, but some of the recommended household items are completely gone. Some are being restocked or produced and will be back. There is still time to get some basics prepared. The time to pick up your medications is sooner rather than later. Get your refills NOW. Suzanne also discusses what’s still available and what can still be done.

Should we get tested for Coronavirus? We need to keep our healthcare workers healthy, make sure your ER visit is valid. We can get more sick from the emergency room. Sometimes staying home is better than going to the hospital. Call ahead of time so they can have a self-quarantined room ready for you. In the US, your county will provide guidance on where to get tested.

Is there a vaccine or other therapy coming out for the virus? There are various companies and treatments on top of the crisis as well as the production of a potential vaccine. Depending on the country that is trying to develop it, there are different methods currently being tested regarding treatment. You may be able to get the virus twice, because there seems to be a mutation. This makes creating a vaccine that much harder. Stay tuned, as Dr. Soliman explains when to keep your kids at home.

Please like, share and leave a comment.

Other Resources:

For a free consultation and for medical affairs consulting, visit: https://rxercommunications.com/

RxER’s newest initiative, Corecentryx, Inc. is a productivity tool that can help us maintain projects and stay energized during this long haul.  As a response to the Coronavirus, Anne Arvizu will be conducting a series of upcoming free livecasts to gather health care professionals and help them combat burnout.  More information will be provided soon at https://annearvizu.com/

For more information about ACMA to become board certified in Medical Affairs visit:  https://training.medicalaffairsspecialist.org/affiliate_page.aspx?unm=anne.aflt.arvizu

To listen to other podcasts on the Pharmacy Podcast Nation, our flagship home on the Pharmacy Podcast Network, subscribe on iTunes or visit: http://pharmacypodcast.com/

If you have something to add to the conversation or would like to be interviewed on the show, contact Anne. https://rxercommunications.com/

 In this Episode:

  • About Dr. Suzanne Soliman and Pharmacist Moms [ 0:15 ]
  • Supplies that we need [ 3:15 ]
  • Should we get tested? [ 11:15 ]
  • Is there a vaccine coming out? [ 17:00 ]
  • Can you get the same virus twice? [ 20:15 ]
  • When should you keep your kids at home? [ 23:10 ]

Quotes:

  • “This is going to get worse before it gets better.” -Dr. Suzanne Soliman
  • “We need to keep our healthcare workers healthy.” -Dr. Suzanne Soliman
  • “Encourage all employees to work remotely if they can.” -Dr. Suzanne Soliman
  • “We see that history repeats itself…don’t get caught up in the news, learn and apply facts” -Dr. Anne Arvizu
  • “Any government has a responsibility to maintain mass hysteria and provide the facts.” -Dr. Anne Arvizu
  • “Knowledge is only power if acted upon.” -Dr. Anne Arvizu

Links Mentioned: 

For those interested: 

For prevention: *Suzanne Soliman’s Article Discussed On This Show*:

Alcohol 70% vs 90 or 99% use:

Published articles:

About Anne:

Dr. Anne Arvizu is founder and CEO of RxER Communications Corp (www.rxercommunications.com). With 22 years of executive leadership experience in the pharma/biotech industry, she has served in key roles such as Head of Global Medical Information, Knowledge Management & Literature Surveillance for Baxter, Baxalta & Shire; Member Executive, PhactMI; International Regional Head & Director of Medical Communications & Medical Information for GSK, LATAM; DIA MASC Program Committee & Track Chair for The Drug Information Association; Podcast Founder & Host for The ACMA (#V3Podcast) (The Accreditation Council For Medical Affairs); Board Member of The American Medical Writers Association (AMWA), and, as an advocate for community health, she serves as Chair, South Florida YMCA Board of Directors in her community. She holds degrees for University of Florida (PharmD), University Of Sciences in Philadelphia, and Villanova University.  Anne currently engages biotech CMOs and VP Level executive clients as an expert consultant for Medical Affairs Capabilities build, renovation, and value-based business expansion.

Please like, share and leave a comment.

#V3PODCAST Episode 6: Antibiotics-The Necessity for Them & the Resistance to Them

Antibiotics-The Necessity for Them & the Resistance to Them

#V3Podcast Episode 6 with Dr. Anne Arvizu and Guest Dr. Jill Massey

Jill Massey is a Senior Medical Affairs Executive with proven success in leading multinational and multi-functional organizations to exceptional business results. An energetic leader recognized for expertise in strategic planning, leadership development, effective business integrations and innovative solutions. Jill combines strong business and clinical experience with nearly 30 years of experience in the pharmaceutical industry following a career in academia and clinical practice.

In this episode, Anne opens the show talking about antibiotic resistance. In our not so distant future, we could see over 10 million lives a year lost to antibiotic resistance. It’s a substantial public health challenge. Each year, 2.8 million people get an antibiotic-resistant infection. As of this recording, it was reported that 1,100 people have died in China from the Coronavirus. Anne gave kudos to the CDC, WHO and other health care organizations that helped create such a rapid and global awareness campaign about this virus, which as we know, its massive reality is still unfolding. We will cover that in an upcoming episode. However, not many people know about antibiotic resistance, despite the also massive threat.

First, Jill explains how antibiotic resistance happens. Jill says that bacteria becoming resistant to antibiotics is a natural phenomenon that occurs over time. The periods of time are shortening as bacteria get smarter. This is entirely expected with repeated exposure to antibiotics.

The two thought leaders ask the question: Where are the new and innovative antibiotics? Jill shares the industry reality regarding when we set up drug development programs, and they are targeting rare, it’s an extremely costly. Once the antibiotics get to the market, the return on investment is minimal. Large pharmaceutical companies are getting out of this business. Instead, they focus on more profitable life-saving treatments. The funding of new antibiotics is difficult to come by, and companies have stopped their development programs out of necessity.

Jill says that we need to practice reasonable infection control, like washing our hands. Then, Jill explains why generic antibiotics are ‘toxic’. Usually, they are equally effective, yet higher in adverse effects. Innovative antibiotics may have less toxicity, but costs to creating them and obtaining them are significantly more.

Later, Jill spoke out about spreading educational and health initiatives to get the word out. Any organization can participate in these needed initiatives to demonstrate what they are doing to tackle the antibiotic resistance challenge. Several organizations are measuring how pharmaceutical companies are tracking the ways they are contributing to resistance.

The number one cure to this issue is ensuring people have access to the right antibiotics. The two discuss RxER’s signature tagline that Anne trademarked and been using since 2004, stating “The Right Drug, for the Right Patient, at the Right Time.” If you are using inferior products, it will interfere with the microbiome and cause additional consequences. Anne says it’s essential to get the right antibiotic, and prescribe, dispense and use only when necessary and educate people on infection control. Don’t demand an antibiotic every time you have a symptom that may or may not be a bacterial infection.

Please like, share and leave a comment.

Other Resources:

For medical affairs consulting, visit: https://rxercommunications.com/

For more about Anne, visit: https://annearvizu.com/

For more information about ACMA to become board certified in Medical Affairs visit:  https://training.medicalaffairsspecialist.org/affiliate_page.aspx?unm=anne.aflt.arvizu

To listen to other podcasts on the Pharmacy Podcast Nation, our flagship home on the Pharmacy Podcast Network, subscribe on iTunes or visit: http://pharmacypodcast.com/


In this Episode:

  • Antibiotics, the necessity for them and the resistance to them [ 1:55 ]
  • Where are the new antibiotics? [ 13:30 ]
  • Bringing awareness to the public [ 16:15 ]
  • Generic antibiotics are toxic [ 17:50 ]
  • Using educational and health initiatives to get the word out [ 19:30 ]
  • How can we bring awareness and mindset to the public at large? [ 20:50 ]
  • Biggest fear globally [ 25:00 ]
  • Importance of infection control [ 26:21 ]
  • Short-term and long-term solutions [ 30:00 ]

Quotes:

  • “There is a broad spectrum of stakeholders involved in antimicrobial resistance.” -Jill Massey
  • “We need education and awareness to combat fear.” -Anne Arvizu
  • “Access to the right antibiotics is a global problem.” -Jill Massey
  • “The lack of new antibiotics has been deemed a threat to antibiotic resistance.” -Anne Arvizu
  • “Companies need the ability to fund further research and development.” -Jill Massey
  • “Young children are prey to antibiotic resistance before they’ve been given an antibiotic because of food sources.” -Anne Arvizu
  • “We need to bring all the stakeholders to the table together and educate them.” -Anne Arvizu

Links Mentioned: 

Please like, share and leave a comment.